Bioextrax Past Earnings Performance
Past criteria checks 0/6
Bioextrax's earnings have been declining at an average annual rate of -40.8%, while the Machinery industry saw earnings growing at 14.2% annually. Revenues have been growing at an average rate of 37.5% per year.
Key information
-40.8%
Earnings growth rate
-22.2%
EPS growth rate
| Machinery Industry Growth | 9.2% |
| Revenue growth rate | 37.5% |
| Return on equity | -108.2% |
| Net Margin | -1,376.3% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Bioextrax makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 2 | -21 | 20 | 0 |
| 31 Mar 24 | 2 | -22 | 22 | 0 |
| 31 Dec 23 | 3 | -22 | 22 | 0 |
| 30 Sep 23 | 3 | -21 | 22 | 0 |
| 30 Jun 23 | 3 | -20 | 22 | 0 |
| 31 Mar 23 | 3 | -20 | 21 | 0 |
| 31 Dec 22 | 2 | -19 | 19 | 0 |
| 30 Sep 22 | 2 | -16 | 16 | 0 |
| 30 Jun 22 | 2 | -14 | 14 | 0 |
| 31 Mar 22 | 1 | -11 | 11 | 0 |
| 31 Dec 21 | 1 | -11 | 10 | 0 |
| 30 Sep 21 | 0 | -10 | 8 | 0 |
| 30 Jun 21 | 0 | -8 | 7 | 0 |
| 31 Mar 21 | 0 | -7 | 6 | 0 |
| 31 Dec 20 | 0 | -6 | 5 | 0 |
| 30 Sep 20 | 0 | -4 | 4 | 0 |
| 30 Jun 20 | 1 | -4 | 4 | 0 |
| 31 Mar 20 | 1 | -2 | 3 | 0 |
| 31 Dec 19 | 1 | -2 | 3 | 0 |
| 31 Dec 18 | 1 | -1 | 1 | 0 |
| 31 Dec 17 | 1 | 0 | 1 | 0 |
| 31 Dec 16 | 0 | 0 | 0 | 0 |
Quality Earnings: BIOEX is currently unprofitable.
Growing Profit Margin: BIOEX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BIOEX is unprofitable, and losses have increased over the past 5 years at a rate of 40.8% per year.
Accelerating Growth: Unable to compare BIOEX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BIOEX is unprofitable, making it difficult to compare its past year earnings growth to the Machinery industry (-5%).
Return on Equity
High ROE: BIOEX has a negative Return on Equity (-108.22%), as it is currently unprofitable.